Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment
Studies Test New Agents Offering Relief From Treatment-Related Side Effects
Oral UFT Equivalent To FULV In Stage II and III Colon Cancer
Adjuvant Chemo Improves Survival In Early Lung Cancer
Treat Cancer, But Protect Heart Anderson Cardiologists Warn
NCI-Approved Clinical Trials
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”